Investment Research & Advisory Group, Inc. Vericel Corp Transaction History

Investment Research & Advisory Group, Inc.

  • $331 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
SELL
$22.88 - $39.45 $4,827 - $8,323
-211 Closed
0 $0
Q4 2021

Jan 19, 2022
BUY
$35.2 - $52.6 $7,427 - $11,098
211 New
211 $8,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.4M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.71B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Investment Research & Advisory Group, Inc. Portfolio

Follow Investment Research & Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research & Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Investment Research & Advisory Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email